These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11351131)

  • 1. Mitochondrial function and alzheimer's disease.
    Ojaimi J; Byrne E
    Biol Signals Recept; 2001; 10(3-4):254-62. PubMed ID: 11351131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.
    Manczak M; Park BS; Jung Y; Reddy PH
    Neuromolecular Med; 2004; 5(2):147-62. PubMed ID: 15075441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitation of brain mitochondrial activity by 5-aminolevulinic acid in a mouse model of Alzheimer's disease.
    Omori C; Motodate R; Shiraki Y; Chiba K; Sobu Y; Kimura A; Nakaya T; Kondo H; Kurumiya S; Tanaka T; Yamamoto K; Nakajima M; Suzuki T; Hata S
    Nutr Neurosci; 2017 Nov; 20(9):538-546. PubMed ID: 27329428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease.
    Grimm A; Friedland K; Eckert A
    Biogerontology; 2016 Apr; 17(2):281-96. PubMed ID: 26468143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative phosphorylation defects and Alzheimer's disease.
    Shoffner JM
    Neurogenetics; 1997 May; 1(1):13-9. PubMed ID: 10735269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional brain metabolism with cytochrome c oxidase histochemistry in a PS1/A246E mouse model of autosomal dominant Alzheimer's disease: correlations with behavior and oxidative stress.
    Strazielle C; Jazi R; Verdier Y; Qian S; Lalonde R
    Neurochem Int; 2009 Dec; 55(8):806-14. PubMed ID: 19682525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inverse-Warburg effect and the origin of Alzheimer's disease.
    Demetrius LA; Simon DK
    Biogerontology; 2012 Dec; 13(6):583-94. PubMed ID: 23086530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer's disease Mouse Brain.
    Fang D; Zhang Z; Li H; Yu Q; Douglas JT; Bratasz A; Kuppusamy P; Yan SS
    J Alzheimers Dis; 2016; 51(2):571-80. PubMed ID: 26890765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Dysfunction in Neocortex and Hippocampus of Olfactory Bulbectomized Mice, a Model of Alzheimer's Disease.
    Avetisyan AV; Samokhin AN; Alexandrova IY; Zinovkin RA; Simonyan RA; Bobkova NV
    Biochemistry (Mosc); 2016 Jun; 81(6):615-23. PubMed ID: 27301290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Alzheimer's disease mitochondrial cascade hypothesis.
    Swerdlow RH; Burns JM; Khan SM
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S265-79. PubMed ID: 20442494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.
    Swerdlow RH; Khan SM
    Med Hypotheses; 2004; 63(1):8-20. PubMed ID: 15193340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    Yu Q; Fang D; Swerdlow RH; Yu H; Chen JX; Yan SS
    J Alzheimers Dis; 2016 Sep; 54(2):679-90. PubMed ID: 27567872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.
    Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology.
    Moreira PI; Carvalho C; Zhu X; Smith MA; Perry G
    Biochim Biophys Acta; 2010 Jan; 1802(1):2-10. PubMed ID: 19853658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron transport chain defects in Alzheimer's disease brain.
    Parker WD; Parks J; Filley CM; Kleinschmidt-DeMasters BK
    Neurology; 1994 Jun; 44(6):1090-6. PubMed ID: 8208407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation.
    Fosslien E
    Ann Clin Lab Sci; 2001 Jan; 31(1):25-67. PubMed ID: 11314862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease.
    Chai YL; Xing H; Chong JR; Francis PT; Ballard CG; Chen CP; Lai MKP
    J Alzheimers Dis; 2018; 61(2):793-801. PubMed ID: 29254089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.